Efficacy and safety of medical treatment for advanced hepatocellular carcinoma

Efficacy and safety of medical treatment for advanced hepatocellular carcinoma - Medical treatment for HCC

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000028440

Enrollment

200

Registered

2017-07-29

Start date

2017-06-22

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular carcinoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Clinically or pathologically diagnosed hepatocellular carcinoma Twenty or more years old Written informed consent

Exclusion criteria

Exclusion criteria: Mental disorder Inappropriate for paticipating the clinical study

Design outcomes

Primary

Measure	Time frame
Overall survival	—

Secondary

Measure	Time frame
Time to progression, Progression-free survival, anti-tumor effect, adverse event, complication, prognostic factor, predictive factor	—

Countries

Japan

Contacts

Public ContactTakeshi Terashima

Kanazawa University Hospital Department of Gastroenterology

tera@m-kanazawa.jp076-265-2235

Outcome results